Clinical Trials on Lv Hypertrophy in Finland

Total 13 results

Rhode Island Hospital

Completed

Lidocaine Infusion for Pain Relief in Children Scheduled for Tonsillectomy and Adenoidectomy

Children, Only | Tonsillar Hypertrophy | Adenoid Hypertrophy

United States
Turku University Hospital

Completed

Long-term Results of Tonsillectomy in the Treatment of Obstructive Sleep Apnea in Adults

Sleep Apnea Syndromes | Obstructive Sleep Apnea | Tonsillar Hypertrophy

Finland
Novartis Pharmaceuticals

Completed

Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension (ALLAY)

Hypertension | Overweight | Left Ventricular Hypertrophy

United States, Finland, Sweden, Germany, Italy, Spain, Argentina, Colombia, Russian Federation
Bristol-Myers Squibb

Recruiting

A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy (MEMENTO)

Cardiomyopathy, Hypertrophic

United States, Argentina, Australia, Belgium, Canada, Czechia, Hungary, Poland, Switzerland, France, Austria, Finland, Germany, Greece, Italy, Spain, United Kingdom
Turku University Hospital

Recruiting

Intracapsular Tonsillectomy in the Treatment of Obstructive Sleep Apnea in Adults

Sleep Apnea, Obstructive | Tonsillar Hypertrophy

Finland
Rhode Island Hospital

Terminated

Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hypertrophy

United States
CardioKinetix, Inc

Terminated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System (PARACHUTE IV)

Congestive Heart Failure | Left Ventricular (LV) Systolic Dysfunction

United States, Canada
GlaxoSmithKline

Completed

The CLEVER Study - Coreg And Left Ventricular Mass Regression

Hypertrophy, Left Ventricular

United States
AEterna Zentaris

Completed

Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) (AEZS-102-Z041)

Benign Prostatic Hypertrophy

United States, Canada
Brigham and Women's Hospital
CVS Caremark

Completed

Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices (REMIND)

Depression | Epilepsy | Cardiovascular Disease | Diabetes | Breast Cancer | Parkinson's Disease | Mental Health Disorder | Prostatic Hypertrophy, Benign

United States
Sanofi

Completed

Clinical Trial in Males With BPH (Enlarged Prostate)

Prostatic Hyperplasia | Urinary Retention | Benign Prostatic Hypertrophy

United States, Canada, Poland, Romania, Australia, Netherlands, Portugal, Spain, Sweden, Bulgaria, Denmark, Finland, Hungary, Norway, South Africa, Greece, Israel
Procter and Gamble

Completed

Study of Oral PG-116800 Following a Heart Attack

Myocardial Infarction | Heart Failure | Heart Enlargement

United States, Canada, Poland
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Nausea | Constipation | Diarrhea | Purpura | Lymphadenopathy | Gastrointestinal Hemorrhage | Hepatomegaly | Primary Systemic Amyloidosis | Amorphous, Eosinophilic, and Acellular Deposit | Early Satiety | Macroglossia | Recurrent Primary Amyloidosis | Refractory Primary Amyloidosis

United States

Clinical Trials on Lv Hypertrophy in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations